Status:
COMPLETED
Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Dyslipidemia
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to show the compliance rates of the patients to statin treatment and the reasons of non-compliance.
Eligibility Criteria
Inclusion
- Patients diagnosed with dyslipidemia and taking or planning to take statin treatment.
- Patients living in the same city of the study center. o Patients aged 18 years and over.
Exclusion
- Patients with severe systemic disease
- Patients with alcohol and drug addiction and/or mental disease
- Patients nursing or pregnant, or planning to get pregnant during the study
Key Trial Info
Start Date :
October 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
375 Patients enrolled
Trial Details
Trial ID
NCT00673660
Start Date
October 1 2007
End Date
October 1 2009
Last Update
February 21 2021
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Mecidiyeköy, Istanbul, Turkey (Türkiye), 34394
2
Pfizer Investigational Site
Bolu, Turkey (Türkiye)
3
Pfizer Investigational Site
Haseki/Istanbul, Turkey (Türkiye), 34390
4
Pfizer Investigational Site
Istanbul, Turkey (Türkiye), 34098